Home › Funds › Kynam Capital Management, LP › MBX

Kynam Capital Management, LP position in MBX

MBX BIOSCIENCES INC COM · Health Care

Kynam Capital Management, LP reported holding 934,799 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$51.6M, representing 2.85% of its reported portfolio and ranking #14 among its reported holdings. Kynam Capital Management, LP has disclosed MBX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)934.80K sh
Reported value held$51.60M
Portfolio Weight2.85%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's MBX position evolved

Kynam Capital Management, LP first disclosed a stake in MBX in Q3 2025 at 2,000,000 shares (US$35.0M). The position peaked in Q2 2026 at 934,799 shares, worth US$51.6M. Across 4 filings, Kynam Capital Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 934,799 shares valued at US$51.6M. Notable position changes include a 53% trim in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.00M $35.00M New
Q4 2025 934.80K $29.48M Reduce
Q1 2026 934.80K $27.90M Hold
Q2 2026 934.80K $51.60M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Kynam Capital Management, LP held MBX?

Kynam Capital Management, LP has disclosed MBX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Kynam Capital Management, LP's current position in MBX?

As of Q2 2026, Kynam Capital Management, LP holds 934.80K shares of MBX (MBX BIOSCIENCES INC COM), valued at $51.60M, representing 2.85% of its reported portfolio and ranking #14.

Has Kynam Capital Management, LP been buying or selling MBX?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP held unchanged its position in MBX. The position peaked in Q2 2026 at 934.80K shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.